| Document |
Document Title |
|
WO/2011/140334 |
The present invention provides various compounds, compositions, and methods. In some embodiments, provided compounds have activity as, for example, inhibitors of protein translation.
|
|
WO/2011/138665 |
The present invention provides dihydroorotate dehydrogenase inhibitors of formula (I), methods of preparing them, pharmaceutical compositions containing them and methods of treatment, prevention and/or amelioration of diseases or disorde...
|
|
WO/2011/134468 |
Novel biaryl compounds with phosphodiesterase inhibitory activity of the general formula (I), wherein R1, R2, R3, X, Y, Z1, Z2, Z3, and Z4 have the meanings defined herein, as well as their use as therapeutic agents in the treatment of i...
|
|
WO/2011/136484 |
Provided are novel organic electroluminescent compounds and an organic electroluminescent device using the same. Since the organic electroluminescent compound exhibits high luminous efficiency in blue color and excellent life property, i...
|
|
WO/2011/136059 |
A novel stable 10,10-dialkylanthrone compound is provided.
|
|
WO/2011/136385 |
The present invention provides to a compound having an ACC inhibitory action, which is useful as an agent for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac failure, diabetic complications, metab...
|
|
WO/2011/134538 |
A novel class of diyne compounds and diyne salts provided herein are effective and potent Ole1 protein inhibitors, useful for treating fungal pathogens. Compounds, fungicides and methods are provided as novel, potent and broad spectrum a...
|
|
WO/2011/132712 |
Provided is a novel compound that is useful as a medical drug in that said compound displays strong antimicrobial activity against gram-negative bacteria such as Pseudomonas aeruginosa and drug-resistant strains thereof, on the basis of ...
|
|
WO/2011/131102 |
Disclosed is a preparation method of a sphaelactone which is prepared form parthenolide sphaelactone as raw material and a suitable acid as catalyst in suitable solvent at suitable reaction temperature and the yield is more than 60%. Als...
|
|
WO/2011/133659 |
Inhibitors of the Hypoxia Inducible Factor (HIF) and angiogenesis and their methods of use including the treatment of cancer, hypoxia related pathologies, disorders leading to ischemia, for example stroke and ischemic heart disease, and ...
|
|
WO/2011/132051 |
The present invention provides Phosphodiesterase- 10 inhibitors. In particular, tricyclic derivatives described herein are useful as Phosphodiesterase- 10 inhibitors. Also provided herein are processes for preparing compounds described h...
|
|
WO/2011/131103 |
Disclosed are sphaelactone derivatives of formula (I) or salts, their pharmaceutical compositions, preparation methods and uses for preparing anti-cancer drugs.
|
|
WO/2011/131135 |
Heteroaryl (alkyl) dithiocarbamate compounds represented by general formula (I) or their pharmaceutical salts, their preparation methods and their uses for preparing antitumor medicines are disclosed, wherein each said substituent is def...
|
|
WO/2011/133659 |
Inhibitors of the Hypoxia Inducible Factor (HIF) and angiogenesis and their methods of use including the treatment of cancer, hypoxia related pathologies, disorders leading to ischemia, for example stroke and ischemic heart disease, and ...
|
|
WO/2011/131881 |
The invention relates to a method for preparing 3-keto-benzofurane derivatives of the general formula: Formula (I), where R is an alkyl or aryl group, R1 is hydrogen or an alkyl or aryl group, and R2 is a substituted alkyl or phenyl grou...
|
|
WO/2011/128431 |
Disclosed are novel cross-linkable end-cappers for oligo-and polyimides. End-capped oligo-and polyimides comprising such an end-capper may be cured at a lower temperature compared to oligo-and polyimides end-capped with PEPA.
|
|
WO/2011/129640 |
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...
|
|
WO/2011/129640 |
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...
|
|
WO/2011/129640 |
The present invention relates to a metal catalyst composition for producing furfural derivatives from raw materials of lignocellulosic biomass, and to a method for producing furfural derivatives using the composition. The metal catalyst ...
|
|
WO/2011/128814 |
In a process for controlling a gas phase oxidation reactor for preparation of phthalic anhydride, by passing a gas stream which comprises an aromatic hydrocarbon and molecular oxygen through a multitude of reaction tubes arranged in the ...
|
|
WO/2011/126082 |
An acyloxypyranone compound represented by formula (II) (wherein R1 represents an acyl group) is produced by causing an acylating agent and a hydrolase to act on hydroxypyranone represented by formula (I) in a hydrous organic solvent; an...
|
|
WO/2011/124639 |
The present invention relates to a method of producing 5-hydroxymethylfurfural by dehydration of fructose and/or glucose and/or mannose.
|
|
WO/2011/126224 |
Organic electroluminescent compounds of Chemical Formula 1 : wherein the variables R1 to R18, Ar, X and m are as defined in the specification. These compounds exhibit good luminous efficiency and excellent life property. As such, they ma...
|
|
WO/2011/125714 |
Provided are novel compounds which can germinate seeds of root-parasitic plants, more specifically, compounds represented by the general formula [wherein R1, R2, R3, R4 and R5 may be the same or different and are each hydrogen, halogen, ...
|
|
WO/2011/124827 |
The invention relates to a process for preparing 5-sulfonamido-benzofuran derivatives of general formula: formula (I) in which R represents an alkyl or aryl group and R1 and R2 represent hydrogen or an alkyl or aryl group. According to t...
|
|
WO/2011/124578 |
The present invention relates to a method for preparing a lactone. The invention relates in particular to the preparation of butyrolactone, valerolactone and caprolactone. The method for preparing a lactone according to the invention is ...
|
|
WO/2011/123269 |
A process for making a hydrogenated product includes providing a clarified DAS- containing fermentation broth; distilling the broth under super atmospheric pressure at a temperature of >100°C to about 300°C to form an overhead that inc...
|
|
WO/2011/121245 |
The invention relates to a process for preparing 5-aminobenzofuran derivatives of general formula: Formula (I), in which R1 is hydrogen or an alkyl group and R2 is an alkyl or dialkylaminoalkyl group. According to the invention, the comp...
|
|
WO/2011/123270 |
A process for making a hydrogenated product includes providing a clarified DAS-containing fermentation broth, distilling the broth to form an overhead that includes water and ammonia, and a liquid bottoms that includes MAS, at least some...
|
|
WO/2011/120912 |
The present invention relates to the use of bicyclic amidine compounds of formula (I) as defined in the description, and the N-oxides, and salts thereof for combating harmful fungi, and also to compositions and seed comprising at least o...
|
|
WO/2011/120912 |
The present invention relates to the use of bicyclic amidine compounds of formula (I) as defined in the description, and the N-oxides, and salts thereof for combating harmful fungi, and also to compositions and seed comprising at least o...
|
|
WO/2011/119461 |
The invention relates to compounds of formula I: (I) where X, HAr, a, and R1 through R6 are as defined in the specification, or a pharmaceutically acceptable salt thereof. The compounds of formula I are serotonin and norepinephrine reupt...
|
|
WO/2011/113920 |
The invention relates to a method for the catalytic gas phase oxidation of hydrocarbons, comprising: a) providing a catalysis reaction device having a reaction space between a gas inlet and a gas outlet, said space being cooled by coolan...
|
|
WO/2011/113284 |
Shikonin naphthazarin derivatives represented by formula I and their preparation method are disclosed, wherein Ri~R4 and R are defined as in the description. The antitumor use of the compounds is also disclosed.
|
|
WO/2011/116275 |
Asymmetrically substituted compounds of bisanhydrohexitols are described, including the bisanhydrohexitol isosorbide. The compounds are useful as AB monomers. The synthesis of polymers from the monomers is also described.
|
|
WO/2011/115378 |
Disclosed are organic electroluminescent compounds and organic electroluminescent devices employing said compounds. The organic electroluminescent compounds of the invention are defined by chemical formula [1], Chemical Formula 1 The com...
|
|
WO/2011/114220 |
Isolated compounds from adelostemma gracillimum refined fractions and compositions containing the compounds are provided by the present invention. Adelostemma gracillimum refined fractions and the extraction process thereof are also prov...
|
|
WO/2011/111738 |
Disclosed are substance FKI-4429-1 represented by formula [I] and three other substances. Filamentous bacteria having the capability of producing this substance FKI-4429-1 are cultured in a medium. The substance FKI-4429-1 accumulates in...
|
|
WO/2011/111677 |
Disclosed is a novel bisphosphate compound that can be used with a wide range of reaction substrates and reactions as a catalyst for asymmetric reactions and can achieve an asymmetric reaction with a high yield and high asymmetric yield....
|
|
WO/2011/112191 |
The disclosure provides compounds of formula (I), including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected...
|
|
WO/2011/111423 |
Disclosed is a method for effectively and inexpensively producing an iodinated aromatic compound without using solvents detrimental to the human body that does not need ligands. Also disclosed is a method for producing a target iodinated...
|
|
WO/2011/107705 |
The present invention relates to ketobenzofuran derivatives of the general formula (D) shown below, as well as to a method for synthesising same by coupling a quinonimine and an enaminone by a Nenitzescu reaction and to the intermediates...
|
|
WO/2011/106992 |
Disclosed are compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preve...
|
|
WO/2011/107720 |
The invention relates to a mixture including: protolichesterinic acid or one of the salts, diastereoisomers or derivatives thereof; and lichesterinic acid or one of the salts, enantiomers or derivatives thereof, to be used for stimulatin...
|
|
WO/2011/106929 |
Compounds of formula I that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infect...
|
|
WO/2011/106986 |
Compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infe...
|
|
WO/2011/106992 |
Disclosed are compounds of formula (I) that are used as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preve...
|
|
WO/2011/104591 |
The invention relates to a new process for the preparation of dronedarone and its salts, in particular a synthesis process which allows said compound and its salts to be obtained with good yields, high purity and in an industrially exped...
|
|
WO/2011/101229 |
The present invention relates to compounds of formula (I) wherein Q is Q1 or Q2 P is P1, heterocyclylor heterocyclyl substituted by one to five Z; and wherein A1, A2, A3, A4, G1, Y1, Z, R1, R2, R3 and R4 are as defined in claim 1; or a s...
|
|
WO/2011/102112 |
An aromatic amine derivative represented by formula (1) (wherein L represents a linking group; Z represents a group represented by formula (2); and A1 and A2 independently represent a monovalent group represented by formula (3)).
|
